Skip to main content
. 2022 Jan 10;10(1):e00910. doi: 10.1002/prp2.910

TABLE 1.

Baseline patient characteristics after 1:1 PS matching

Category SGLT‐2 inhibitors (7738) DPP‐4 inhibitors (7738) STD (%) SGLT‐2 inhibitors (7145) SU (7145) STD (%) SGLT‐2 inhibitors (2175) TZD (2175) STD (%)
N % N % N % N % N % N %
Sex
Male 5181 66.96 5184 66.99 −0.1 4877 68.26 4862 68.05 0.5 1489 68.46 1509 69.38 −2.0
Female 2557 33.04 2554 33.01 0.1 2268 31.74 2283 31.95 −0.5 686 31.54 666 30.62 2.0
Age
Mean (SD) 47.6 (11.0) 48.0 (0.9) −5.1 48.3 (10.8) 48.9 (10.9) −5.5 52.5 (11.3) 53.1 (11.3) −5.3
19–29 401 5.18 386 4.99 0.9 277 3.88 277 3.88 0.0 63 2.90 61 2.80 0.6
30–39 1335 17.25 1363 17.61 −1.0 1143 16.00 1140 15.96 0.1 177 8.14 172 7.91 0.8
40–49 2571 33.23 2587 33.43 −0.4 2370 33.17 2353 32.93 0.5 546 25.10 541 24.87 0.5
50–59 2414 31.20 2398 30.99 0.4 2348 32.86 2337 32.71 0.3 783 36.00 796 36.60 −1.2
60–69 853 11.02 841 10.87 0.5 844 11.81 866 12.12 −0.9 467 21.47 482 22.16 −1.7
70–79 143 1.85 144 1.86 −0.1 142 1.99 147 2.06 −0.5 121 5.56 107 4.92 2.9
80+ 21 0.27 19 0.25 0.5 21 0.29 25 0.35 −1.0 18 0.83 16 0.74 1.0
Drug use
Broad spectrum antibiotic 1742 22.51 1712 22.12 0.9 1526 21.36 1504 21.05 0.8 440 20.23 411 18.90 3.4
NSAIDs 2749 35.53 2750 35.54 0.0 2511 35.14 2539 35.54 −0.8 771 35.45 737 33.89 3.3
Estrogen 36 0.47 36 0.47 0.0 31 0.43 31 0.43 0.0 5 0.23 8 0.37 −2.5
Antifungal drugs 695 8.98 682 8.81 0.6 592 8.29 611 8.55 −1.0 163 7.49 158 7.26 0.9
Antihypertensive agent 3215 41.55 3187 41.19 0.7 2903 40.63 2882 40.34 0.6 916 42.11 934 42.94 −1.7
Anticonvulsants 5 0.06 4 0.05 0.5 4 0.06 8 0.11 −1.9 1 0.05 1 0.05 0.0
Immunosuppressive drug 0.0 0.0 0.0
Systemic steroid 23 0.30 15 0.19 2.1 21 0.29 15 0.21 1.7 8 0.37 6 0.28 1.6
CCI
Mean (SD) 1.5 (1.0) 1.5 (1.0) 0.0 1.5 (1.2) 1.5 (1.3) 0.0 1.5 (1.1) 1.5 (1.1) 0.0
0 1699 21.96 1723 22.27 −0.7 1684 23.57 1682 23.54 0.1 495 22.76 535 24.60 −4.3
1 2329 30.10 2316 29.93 0.4 2197 30.75 2225 31.14 −0.8 597 27.45 580 26.67 1.8
2 2192 28.33 2137 27.62 1.6 1989 27.84 1898 26.56 2.9 601 27.63 608 27.95 −0.7
3+ 1518 19.62 1562 20.19 −1.4 1275 17.84 1340 18.75 −2.4 482 22.16 452 20.78 3.4
Medical treatment
Diabetes, complicated 1270 16.41 1256 16.23 0.5 1058 14.81 1052 14.72 0.2 367 16.87 377 17.33 −1.2
Diabetes, uncomplicated 4357 56.31 4369 56.46 −0.3 3915 54.79 3985 55.77 −2.0 1184 54.44 1180 54.25 0.4
Renal diseases 46 0.59 51 0.66 −0.8 35 0.49 37 0.52 −0.4 12 0.55 11 0.51 0.6
Stroke 195 2.52 178 2.30 1.4 173 2.42 165 2.31 0.7 87 4.00 85 3.91 0.5
Ischemic heart disease 12 0.16 7 0.09 1.8 7 0.10 7 0.10 0.0 3 0.14 5.3
Hypertension, uncomplicated 295 3.81 283 3.66 0.8 217 3.04 227 3.18 −0.8 65 2.99 60 2.76 1.4
Hypertension, complicated 3190 41.23 3165 40.90 0.7 2876 40.25 2855 39.96 0.6 889 40.87 901 41.43 −1.1
Hyperlipidemia 4310 55.70 4333 56.00 −0.6 3790 53.04 3839 53.73 −1.4 1208 55.54 1206 55.45 0.2
Congestive heart failure 229 2.96 219 2.83 0.8 170 2.38 165 2.31 0.5 40 1.84 37 1.70 1.0
Cardiac arrhythmias 223 2.88 185 2.39 3.1 184 2.58 180 2.52 0.4 58 2.67 49 2.25 2.7
Valvular disease 28 0.36 21 0.27 1.6 15 0.21 18 0.25 −0.9 10 0.46 9 0.41 0.7
Chronic pulmonary diseases 1008 13.03 991 12.81 0.7 862 12.06 907 12.69 −1.9 297 13.66 294 13.52 0.4
Pulmonary circulation disorders 5 0.06 4 0.05 0.5 3 0.04 6 0.08 −1.7 2 0.09 4.3
Asthma 8 0.10 2 0.03 3.1 4 0.06 5 0.07 −0.6 3 0.14 1 0.05 3.0
Peripheral vascular disease 432 5.58 476 6.15 −2.4 410 5.74 398 5.57 0.7 193 8.87 179 8.23 2.3
Hemiplegia 11 0.14 8 0.10 1.1 10 0.14 8 0.11 0.8 6 0.28 8 0.37 −1.6
Neurodegenerative disorders 55 0.71 48 0.62 1.1 52 0.73 45 0.63 1.2 25 1.15 13 0.60 5.9
Hypothyroidism 316 4.08 316 4.08 0.0 264 3.69 266 3.72 −0.1 84 3.86 85 3.91 −0.2
Liver disease 2677 34.60 2655 34.31 0.6 2386 33.39 2464 34.49 −2.3 727 33.43 699 32.14 2.7
Peptic ulcer disease, no bleeding 664 8.58 667 8.62 −0.1 606 8.48 612 8.57 −0.3 204 9.38 194 8.92 1.6
Rheumatoid arthritis/collagen vascular diseases 90 1.16 122 1.58 −3.6 83 1.16 85 1.19 −0.3 37 1.70 35 1.61 0.7
Coagulopathy 18 0.23 18 0.23 0.0 14 0.20 18 0.25 −1.2 4 0.18 5 0.23 −1.0
Obesity 39 0.50 33 0.43 1.1 15 0.21 13 0.18 0.6 4 0.18 5 0.23 −1.0
Weight loss 22 0.28 13 0.17 2.4 22 0.31 21 0.29 0.3 8 0.37 5 0.23 2.5
Fluid and electrolyte disorders 225 2.91 191 2.47 2.7 186 2.60 166 2.32 1.8 50 2.30 46 2.11 1.3
Blood loss anemia 13 0.17 18 0.23 −1.4 10 0.14 10 0.14 0.0 2 0.09 4 0.18 −2.5
Deficiency anemia 281 3.63 245 3.17 2.6 258 3.61 256 3.58 0.2 82 3.77 86 3.95 −1.0
Alcohol abuse 200 2.58 226 2.92 −2.1 184 2.58 202 2.83 −1.6 61 2.80 67 3.08 −1.6
Drug abuse 1 0.01 3 0.04 −1.6 2 0.03 −2.4 0.0
Psychosis 64 0.83 73 0.94 −1.2 63 0.88 61 0.85 0.3 23 1.06 21 0.97 0.9
Depression 231 2.99 208 2.69 1.8 198 2.77 212 2.97 −1.2 83 3.82 81 3.72 0.5
Pregnancy 12 0.16 11 0.14 0.3 5 0.07 3 0.04 1.2 1 0.05 2 0.09 −1.8